Recent update from the regulatory landscape in clinical data management
Date: September 24, 2026
On 22 September, MHRA published a new set of inspection dossier documents specifically for computerized systems in support of clinical trials.
You can download the new templates on the MHRA GCP hub: https://www.gov.uk/guidance/clinical-trials-for-medicines-good-clinical-practice-inspections
Scroll down to the Pre-inspection documentation tab to find the:
- GCP inspection dossier template – Computerised Systems
- GCP inspection dossier clinical trial spreadsheet – Computerised Systems
- GGP inspection dossier checklist – Computerised Systems.
MHRA last updated the dossier documents in Dec 2025 to include a new section 13 on Artificial Intelligence and Machine Learning (AI/ML). The new Computerized Systems documents continue the focus on managing and documenting usage of AI/ML and traditional computerized systems.
An initial review of the new documents underscores the MHRA emphasis on risk management throughout the entire software development lifecycle including validation status and change control.
For example in the inspection dossier spreadsheet, the tab S1 Item 4- clinical trials includes questions such as:
- Number of substantial protocol amendments/modifications
- Number of change controls
- How many of these change controls related to a protocol amendment/modification
The ACDM DMEG for Regulatory considerations recommends that data managers review the new documents to ensure that their validation and documentation efforts will support MHRA inspections.
Explore More News

Recent News in Regulatory Landscape
The ACDM Regulatory Considerations DMEG have kindly put together a short news piece . . .
Read More

Real-Time Clinical Data Flow: Why the FDA’s New Pilot Validates the Data Flow Modernization Agenda
Tamer Chowdhury, on behalf of ACDM Technology DMEG.
On April 28, FDA Commissioner Dr. . . .
Read More

Bridging the Behaviour Gap: The Human Skills Redefining Clinical Data Management (ACDM26 Workshop Recap)
This article has been written by Gail Kniveton, who delivered the workshop “Bridging the . . .
Read More

Regulatory Considerations DMEG reviews recent MHRA regulatory updates
The ACDM Regulatory considerations DMEG Regulatory considerations reviewed several recent . . .
Read More

ACDM26 Berlin: Shaping the Future of Clinical Data Management
The ACDM Annual Conference returned to Berlin in March 2026, welcoming the global clinical . . .
Read More

Member News Update from Lab Data Solutions LLC
This news piece has been submitted by Lab Data Solutions LLC
We’re Attending US Summit . . .
Read More

Welcome Veramed as a corporate member
The Association for Clinical Data Management (ACDM) is delighted to welcome Veramed as a . . .
Read More

Welcome CROss Alliance as a corporate member
The Association for Clinical Data Management (ACDM) is delighted to welcome CROss Alliance . . .
Read More

Regulatory Considerations DMEG Update
With mixed feelings, we share that Silvia Pérez Torres, current chair of the ACDM . . .
Read More

Newsletter Committee’s Christmas Copilot Tips
In a time when we are constantly surrounded by artificial intelligence and feel the need . . .
Read More

Welcome Data Magik as a corporate member
The Association for Clinical Data Management (ACDM) is delighted to welcome Data Magik as . . .
Read More

Welcome The Institute of Cancer Research – Scientific Computing as a corporate member
The Association for Clinical Data Management (ACDM) is delighted to welcome The Institute . . .
Read More